• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌性 Merkel 细胞多瘤病毒 T 抗原截断突变是 Merkel 细胞癌中 APOBEC3 活性介导的。

Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma.

机构信息

Unit of Infection and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.

Turku Doctoral Programme of Molecular Medicine, University of Turku, Turku, Finland.

出版信息

Cancer Res Commun. 2022 Nov 4;2(11):1344-1354. doi: 10.1158/2767-9764.CRC-22-0211. eCollection 2022 Nov.

DOI:10.1158/2767-9764.CRC-22-0211
PMID:36970060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10035372/
Abstract

UNLABELLED

Merkel cell carcinoma (MCC) is an aggressive skin cancer, which is frequently caused by Merkel cell polyomavirus (MCPyV). Mutations of MCPyV tumor (T) antigens are major pathologic events of virus-positive (MCPyV+) MCCs, but their source is unclear. Activation-induced cytidine deaminase (AID)/APOBEC family cytidine deaminases contribute to antiviral immunity by mutating viral genomes and are potential carcinogenic mutators. We studied the contribution of AID/APOBEC cytidine deaminases to MCPyV large T (LT) truncation events. The MCPyV area in MCCs was enriched with cytosine-targeting mutations, and a strong APOBEC3 mutation signature was observed in MCC sequences. and expression were detected in the Finnish MCC sample cohort, and expression correlated with and . Marginal but statistically significant somatic hypermutation targeting activity was detected in the MCPyV regulatory region. Our results suggest that APOBEC3 cytidine deaminases are a plausible cause of the truncating mutations in MCPyV+ MCC, while the role of AID in MCC carcinogenesis is unlikely.

SIGNIFICANCE

We uncover APOBEC3 mutation signature in MCPyV that reveals the likely cause of mutations underlying MCPyV+ MCC. We further reveal an expression pattern of APOBECs in a large Finnish MCC sample cohort. Thus, the findings presented here suggest a molecular mechanism underlying an aggressive carcinoma with poor prognosis.

摘要

未加标签

Merkel 细胞癌(MCC)是一种侵袭性皮肤癌,常由 Merkel 细胞多瘤病毒(MCPyV)引起。MCPyV 肿瘤(T)抗原的突变是病毒阳性(MCPyV+)MCC 的主要病理事件,但它们的来源尚不清楚。激活诱导的胞苷脱氨酶(AID)/APOBEC 家族胞苷脱氨酶通过突变病毒基因组有助于抗病毒免疫,是潜在的致癌突变剂。我们研究了 AID/APOBEC 胞苷脱氨酶对 MCPyV 大 T(LT)截短事件的贡献。MCC 中的 MCPyV 区域富含靶向胞嘧啶的突变,并且在 MCC 序列中观察到强烈的 APOBEC3 突变特征。在芬兰 MCC 样本队列中检测到 和 的表达,并且 表达与 和 相关。在 MCPyV 调节区检测到针对边缘化但具有统计学意义的体细胞超突变靶向活性。我们的结果表明,APOBEC3 胞苷脱氨酶可能是 MCPyV+MCC 中 LT 截断突变的合理原因,而 AID 在 MCC 癌变中的作用不太可能。

意义

我们在 MCPyV 中揭示了 APOBEC3 突变特征,揭示了导致 MCPyV+MCC 突变的潜在原因。我们进一步揭示了 APOBEC 在大型芬兰 MCC 样本队列中的表达模式。因此,这里提出的发现提出了一种具有不良预后的侵袭性癌的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/8c351ad1a551/crc-22-0211_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/9c2e70b16485/crc-22-0211_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/a7aba9c6983d/crc-22-0211_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/7ea94d73c31f/crc-22-0211_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/8c351ad1a551/crc-22-0211_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/9c2e70b16485/crc-22-0211_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/a7aba9c6983d/crc-22-0211_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/7ea94d73c31f/crc-22-0211_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/10035372/8c351ad1a551/crc-22-0211_fig4.jpg

相似文献

1
Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma.致癌性 Merkel 细胞多瘤病毒 T 抗原截断突变是 Merkel 细胞癌中 APOBEC3 活性介导的。
Cancer Res Commun. 2022 Nov 4;2(11):1344-1354. doi: 10.1158/2767-9764.CRC-22-0211. eCollection 2022 Nov.
2
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.鉴定六株 Merkel 细胞多瘤病毒阳性 Merkel 细胞癌细胞系:整合模式表明,大 T 抗原截断事件发生在整合之前或整合过程中。
Int J Cancer. 2019 Aug 15;145(4):1020-1032. doi: 10.1002/ijc.32280. Epub 2019 Apr 4.
3
LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma.LT 和 SOX9 的表达与基因集相关,这些基因集可以区分 Merkel 细胞多瘤病毒(MCPyV)阳性和 MCPyV 阴性 Merkel 细胞癌。
Br J Dermatol. 2024 May 17;190(6):876-884. doi: 10.1093/bjd/ljae033.
4
RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.RB1是默克尔细胞多瘤病毒大T抗原在默克尔细胞癌细胞中的关键靶点。
Oncotarget. 2016 May 31;7(22):32956-68. doi: 10.18632/oncotarget.8793.
5
The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression.默克尔细胞多瘤病毒的 T 抗原基因座下调人 Toll 样受体 9 的表达。
J Virol. 2013 Dec;87(23):13009-19. doi: 10.1128/JVI.01786-13. Epub 2013 Sep 25.
6
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.多学科治疗,包括局部化疗,用于 Merkel 多瘤病毒阳性 Merkel 细胞癌:表现出神经营养因子受体 Tropomyosin-Related Kinase A 致癌性替代 Δ exon 6-7 TrkAIII 剪接的患者的观点。
Int J Mol Sci. 2020 Nov 3;21(21):8222. doi: 10.3390/ijms21218222.
7
Merkel cell polyomavirus and non-Merkel cell carcinomas: guilty or circumstantial evidence? Merkel 细胞多瘤病毒与非 Merkel 细胞癌:确凿证据还是间接证据?
APMIS. 2020 Feb;128(2):104-120. doi: 10.1111/apm.13019. Epub 2020 Jan 28.
8
High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.高亲和力 Rb 结合、p53 抑制、亚细胞定位以及野生型或肿瘤衍生的缩短 Merkel 细胞多瘤病毒大 T 抗原的转化。
J Virol. 2014 Mar;88(6):3144-60. doi: 10.1128/JVI.02916-13. Epub 2013 Dec 26.
9
Decreased H3K27me3 Expression Is Associated With Merkel Cell Polyomavirus-negative Merkel Cell Carcinoma, Especially Combined With Cutaneous Squamous Cell Carcinoma.H3K27me3 表达降低与 Merkel 细胞多瘤病毒阴性 Merkel 细胞癌相关,尤其是与皮肤鳞状细胞癌合并时。
Anticancer Res. 2019 Oct;39(10):5573-5579. doi: 10.21873/anticanres.13751.
10
Current In Vitro and In Vivo Models to Study MCPyV-Associated MCC.研究 MCPyV 相关 MCC 的当前体外和体内模型。
Viruses. 2022 Oct 7;14(10):2204. doi: 10.3390/v14102204.

引用本文的文献

1
Viral infection, APOBEC3 dysregulation, and cancer.病毒感染、载脂蛋白B mRNA编辑酶催化多肽样3(APOBEC3)失调与癌症
Front Genet. 2024 Dec 23;15:1489324. doi: 10.3389/fgene.2024.1489324. eCollection 2024.
2
The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity.SV40病毒增强子作为一种具有潜在致瘤活性的体细胞超突变靶向元件发挥作用。
Tumour Virus Res. 2024 Dec;18:200293. doi: 10.1016/j.tvr.2024.200293. Epub 2024 Oct 28.
3
The Role of the Large T Antigen in the Molecular Pathogenesis of Merkel Cell Carcinoma.

本文引用的文献

1
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.肿瘤浸润 B 细胞:免疫机制、临床影响和治疗机会。
Nat Rev Cancer. 2022 Jul;22(7):414-430. doi: 10.1038/s41568-022-00466-1. Epub 2022 Apr 7.
2
Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome.默克尔细胞多瘤病毒:稳定基因组中的致癌作用。
Viruses. 2021 Dec 30;14(1):58. doi: 10.3390/v14010058.
3
IFN-γ‒Induced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma.IFN-γ 诱导的 APOBEC3B 导致 Merkel 细胞癌中 Merkel 细胞多瘤病毒基因组发生突变。
大 T 抗原在 Merkel 细胞癌分子发病机制中的作用。
Genes (Basel). 2024 Aug 27;15(9):1127. doi: 10.3390/genes15091127.
4
The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses.载脂蛋白B编辑酶催化多肽样蛋白3(APOBEC3)家族蛋白与DNA肿瘤病毒之间的复杂相互作用
Pathogens. 2024 Feb 20;13(3):187. doi: 10.3390/pathogens13030187.
5
Human DNA tumor viruses evade uracil-mediated antiviral immunity.人类DNA肿瘤病毒逃避尿嘧啶介导的抗病毒免疫。
PLoS Pathog. 2023 Mar 30;19(3):e1011252. doi: 10.1371/journal.ppat.1011252. eCollection 2023 Mar.
J Invest Dermatol. 2022 Jul;142(7):1793-1803.e11. doi: 10.1016/j.jid.2021.12.019. Epub 2021 Dec 28.
4
Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.免疫球蛋白增强子增加 RNA 聚合酶 II 在体细胞超突变靶序列处的停滞。
J Immunol. 2022 Jan 1;208(1):143-154. doi: 10.4049/jimmunol.2100923. Epub 2021 Dec 3.
5
LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers.LRIG1是默克尔细胞癌的一个阳性预后标志物,且默克尔细胞癌表达上皮干细胞标志物。
Virchows Arch. 2021 Dec;479(6):1197-1207. doi: 10.1007/s00428-021-03158-7. Epub 2021 Jul 31.
6
Interactions of APOBEC3s with DNA and RNA.APOBEC3 与 DNA 和 RNA 的相互作用。
Curr Opin Struct Biol. 2021 Apr;67:195-204. doi: 10.1016/j.sbi.2020.12.004. Epub 2021 Jan 22.
7
Molecular origins of APOBEC-associated mutations in cancer.癌症中 APOBEC 相关突变的分子起源。
DNA Repair (Amst). 2020 Oct;94:102905. doi: 10.1016/j.dnarep.2020.102905. Epub 2020 Jul 6.
8
Footprint of the host restriction factors APOBEC3 on the genome of human viruses.宿主限制因子 APOBEC3 在人类病毒基因组上的足迹。
PLoS Pathog. 2020 Aug 14;16(8):e1008718. doi: 10.1371/journal.ppat.1008718. eCollection 2020 Aug.
9
The landscape of viral associations in human cancers.人类癌症中病毒相关性的全景。
Nat Genet. 2020 Mar;52(3):320-330. doi: 10.1038/s41588-019-0558-9. Epub 2020 Feb 5.
10
Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation.拓扑关联域划定体细胞超突变易感性。
Cell Rep. 2019 Dec 17;29(12):3902-3915.e8. doi: 10.1016/j.celrep.2019.11.039.